DUBLIN--(BUSINESS WIRE)--The "Global Womens Health Diagnostics Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
The Global Women's Health Diagnostics Market is poised for strong growth during the forecast period 2017 to 2027
This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies for the existing players, new entrants and the future investors.
Some of the prominent trends that the market is witnessing include rapid growth in breast cancer screening, developing healthcare infrastructure, recent technological developments of women's health diagnostics and growth opportunities/investment opportunities.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Womens Health Diagnostics Market, By Application
5 Womens Health Diagnostics Market, By End User
6 Womens Health Diagnostics Market, By Geography
7 Key Player Activities
8 Leading Companies
- Koninklijke Philips N.V.
- Abbott Laboratories
- GE Healthcare
- Perkinelmer Inc.
- Hologic, Inc.
- Siemens AG
- Biomrieux SA
- Becton, Dickinson and Company
- Alere Inc.
- F. Hoffmann-La Roche AG
- Quest Diagnostics Inc.
- ACON Laboratories
- Bio-Rad Laboratories
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/6dq79l/global_womens?w=4